LICENSE AGREEMENT effective February 26, 2016 between ALBA THERAPEUTICS CORPORATION and INNOVATE BIOPHARMACEUTICALS, INC.License Agreement • June 29th, 2018 • Innovate Biopharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJune 29th, 2018 Company Industry JurisdictionThis License Agreement (“Agreement”) effective as of February 26, 2016 (“Effective Date”) is made by and between Alba Therapeutics Corporation, a Delaware corporation (“Alba”), having an address at 100 International Drive, 23rd Floor, Baltimore, MD 21202, and Innovate Biopharmaceuticals, Inc., a Delaware corporation, having an address at 8601 Six Forks Road, Suite 400, Raleigh, NC 27615 (“Company”).
LICENSE AGREEMENT effective February 26, 2016 between ALBA THERAPEUTICS CORPORATION and INNOVATE BIOPHARMACEUTICALS, INC.License Agreement • March 14th, 2018 • Innovate Biopharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 14th, 2018 Company Industry JurisdictionThis License Agreement (“Agreement”) effective as of February 26, 2016 (“Effective Date”) is made by and between Alba Therapeutics Corporation, a Delaware corporation (“Alba”), having an address at 100 International Drive, 23rd Floor, Baltimore, MD 21202, and Innovate Biopharmaceuticals, Inc., a Delaware corporation, having an address at 8601 Six Forks Road, Suite 400, Raleigh, NC 27615 (“Company”).